{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T10:40:01Z","timestamp":1756377601602,"version":"3.44.0"},"reference-count":18,"publisher":"BMJ","issue":"7","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2025,6,5]]},"published-print":{"date-parts":[[2025,7]]},"abstract":"<jats:p>Rheumatoid vasculitis (RV) is a rare and severe extra-articular complication of rheumatoid arthritis (RA), typically occurring in patients with longstanding and erosive RA. It most commonly involves small and medium sized vessels, but it can also affect large vessels. In this case report, we present a patient with de novo RV who developed multisystem vasculitis that affected small, medium and large vessels prior to the diagnosis of RA. The patient had markedly elevated rheumatoid factor (RF) and anti-cyclic citrullinated peptide (anti-CCP) antibodies, confirming the diagnosis of RV. This case highlights the challenge of diagnosing RV in the absence of prior RA.<\/jats:p>","DOI":"10.1136\/bcr-2025-266022","type":"journal-article","created":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T00:00:29Z","timestamp":1751587229000},"page":"e266022","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Rheumatoid variable vessel vasculitis concurrently affecting small, medium and large vessels"],"prefix":"10.1136","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-5089-7030","authenticated-orcid":false,"given":"Andrew Bernard","family":"Xu","sequence":"first","affiliation":[{"name":"Rheumatology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5142-8707","authenticated-orcid":false,"given":"Ian","family":"Liang","sequence":"additional","affiliation":[{"name":"Rheumatology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia"},{"name":"The University of Sydney Faculty of Medicine and Health, Camperdown, New South Wales, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew","family":"Parker","sequence":"additional","affiliation":[{"name":"Rheumatology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia"},{"name":"The University of Sydney Faculty of Medicine and Health, Camperdown, New South Wales, Australia"},{"name":"The Institute for Academic Medicine, Royal Prince Alfred Hospital, Sydney, NSW, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2025,7,3]]},"reference":[{"key":"2025082803272894000_18.7.e266022.1","doi-asserted-by":"crossref","first-page":"103391","DOI":"10.1016\/j.autrev.2023.103391","article-title":"Rheumatoid vasculitis in 2023: Changes and challenges since the biologics era","volume":"22","author":"Mertz","year":"2023","journal-title":"Autoimmun Rev"},{"key":"2025082803272894000_18.7.e266022.2","doi-asserted-by":"crossref","first-page":"57","DOI":"10.5152\/eurjrheum.2017.160058","article-title":"Can rheumatoid vasculitis predate a diagnosis of rheumatoid arthritis?","volume":"4","author":"Sacks","year":"2017","journal-title":"Eur J Rheumatol"},{"key":"2025082803272894000_18.7.e266022.3","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(84)90654-5"},{"key":"2025082803272894000_18.7.e266022.4","doi-asserted-by":"crossref","DOI":"10.1186\/1756-0500-5-447","article-title":"Bronchiectasis and hoarseness of voice in takayasu arteritis: a rare presentation","volume":"5","author":"Nd Perera","year":"2012","journal-title":"BMC Res Notes"},{"key":"2025082803272894000_18.7.e266022.5","doi-asserted-by":"crossref","first-page":"162","DOI":"10.18773\/austprescr.2006.097","article-title":"Abnormal Laboratory Results: Antibodies to cyclic citrullinated peptides: how they assist in the diagnosis of rheumatoid arthritis","volume":"29","author":"Langguth","year":"2006","journal-title":"Aust Prescr"},{"key":"2025082803272894000_18.7.e266022.6","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000025558","article-title":"Low levels of anti-cyclic citrullinated peptide (CCP) 3.1 associated with diseases other than rheumatoid arthritis","volume":"100","author":"Son","year":"2021","journal-title":"Medicine (Baltimore)"},{"key":"2025082803272894000_18.7.e266022.7","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1111\/1756-185X.12552","article-title":"Diagnostic performance of anti-cyclic citrullinated peptide and rheumatoid factor in patients with rheumatoid arthritis","volume":"19","author":"Chang","year":"2016","journal-title":"Int J Rheum Dis"},{"key":"2025082803272894000_18.7.e266022.8","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.09.3401"},{"key":"2025082803272894000_18.7.e266022.9","doi-asserted-by":"crossref","DOI":"10.1007\/s11926-017-0667-3","article-title":"Rheumatoid Vasculitis: A Diminishing Yet Devastating Menace","volume":"19","author":"Kishore","year":"2017","journal-title":"Curr Rheumatol Rep"},{"key":"2025082803272894000_18.7.e266022.10","doi-asserted-by":"crossref","first-page":"1103065","DOI":"10.3389\/fmed.2023.1103065","article-title":"Pathophysiology and clinical manifestations of immune complex vasculitides","volume":"10","author":"Sunderk\u00f6tter","year":"2023","journal-title":"Front Med"},{"key":"2025082803272894000_18.7.e266022.11","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/ket326"},{"key":"2025082803272894000_18.7.e266022.12","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.101133"},{"key":"2025082803272894000_18.7.e266022.13","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/00005792-198903000-00003","article-title":"Rheumatoid aortitis: a rarely recognized but clinically significant entity","volume":"68","author":"Gravallese","year":"1989","journal-title":"Medicine (Baltimore)"},{"key":"2025082803272894000_18.7.e266022.14","doi-asserted-by":"publisher","DOI":"10.1016\/S1010-7940(98)00294-2"},{"key":"2025082803272894000_18.7.e266022.15","doi-asserted-by":"publisher","DOI":"10.1002\/art.27584"},{"key":"2025082803272894000_18.7.e266022.16","doi-asserted-by":"crossref","DOI":"10.1186\/2193-1801-3-509","article-title":"Rheumatoid arthritis-associated aortitis: a case report and literature review","volume":"3","author":"Kaneko","year":"2014","journal-title":"Springerplus"},{"key":"2025082803272894000_18.7.e266022.17","doi-asserted-by":"publisher","DOI":"10.1097\/BOR.0000000000000126"},{"key":"2025082803272894000_18.7.e266022.18","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/S0190-9622(86)70202-8","article-title":"Oral methotrexate therapy for chronic rheumatoid arthritis ulcerations","volume":"15","author":"Espinoza","year":"1986","journal-title":"J Am Acad Dermatol"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2025-266022","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T10:27:33Z","timestamp":1756376853000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2025-266022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":18,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2025,7,3]]},"published-print":{"date-parts":[[2025,7]]}},"alternative-id":["10.1136\/bcr-2025-266022"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2025-266022","relation":{},"ISSN":["1757-790X"],"issn-type":[{"type":"electronic","value":"1757-790X"}],"subject":[],"published":{"date-parts":[[2025,7]]}}}